Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

James Wood Johnson

Edward Mead Johnson

Robert Wood Johnson

Johnson & Johnson

Lensmarket.bg offers a variety of contact lenses, including daily, monthly, and specialty lenses, along with care solutions, tailored for users' specifications.

Lensmarket.bg

山东前沿医疗器械股份有限公司 manufactures medical ozone therapy devices and other medical equipment, self-described as a high-tech enterprise.

山东前沿医疗器械股份有限公司

Acerta Pharma, an affiliate of AstraZeneca, develops and delivers targeted novel transformational medicines for patients with hematological malignancies.  Acerta Pharma uses innovative approaches to discover, develop, and deliver targeted medicines, focusing on innovative clinical strategies and resistance biology.

Metric
Company Name	Johnson & Johnson	Lensmarket.bg	山东前沿医疗器械股份有限公司	Acerta Pharma
Symbol	JNJ
MSH ID	COM:JNJ	BG:LENSMARKET	CN:COM:ZAMT	COM:ACERTA-PHARMA
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Consumer Goods	Healthcare & Health Services	Healthcare & Health Services
Industry	Drug Manufacturers - General	Optical Retail	Medical Devices	Pharmaceutical
Country	US	BG	CN	NL
Stage
Employee Count	131.90K
Website	jnj.com	lensmarket.bg	zamt.com.cn	acerta-pharma.com
LinkedIn	johnson-&-johnson	lensmarket-bg
Founders

Metric
Market Cap	359.63B
Enterprise Value
Monthly Web Traffic	2.26M	355.66K
Web Traffic Growth	0.02	-0.38
Valuation
Raised Capital

Metric
Revenue	85.15B
Revenue (LTM)
Revenue (NTM)
Gross Profit	58.41B
EBITDA	29.34B
Operating Income	21.85B
Net Income	14.17B
EPS	5.59
Diluted EPS	5.53
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.71
Operating Profit Margin	0.30
EBITDA Margin	0.34
Net Profit Margin	0.45
Return on Equity	0.57
Return on Assets	0.24
Return on Capital Employed	0.21

COM:JNJ

Johnson & Johnson

Last Close

155.50

22/11 21:00

Market Cap

359.63B

Beta: -

Volume Today

5.56M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	10.85
P/B Ratio	5.27
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	4.66
EV Multiple	13.83

Metric
Days Sales Outstanding	56.66
Days Payables Outstanding	98.44
Days Inventory Outstanding	178.66
Operating Cycle	245.26
Cash Conversion Cycle	115.35
Asset Turnover	0.56

Metric
Operating Cash Flow	22.79B
Free Cash Flow	18.25B
Cash Flow to Debt	0.78
Operating Cash Flow/Sales	0.28
Free Cash Flow Yield	0.04

Metric
Cash & Equivalents	21.86B
Accounts Receivable	-624M
Inventory	11.18B
Goodwill	36.56B
Debt to Capitalization	0.37
Debt to Assets	0.18
Current Ratio	1.21
Quick Ratio	0.94

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue	0.16
SG&A to Revenue	0.06